Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment (GrannyFit)
Breast Cancer
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring digital, activity tracker, lifestyle, prevention
Eligibility Criteria
Inclusion Criteria: Women over 70 years of age, With histologically confirmed invasive breast cancer, Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-), with or without HER2 overexpression, or triple negative) Treated with local (surgery, radiotherapy) or systemic (hormone therapy, monotherapy, anti HER2, chemotherapy: patient is eligible for inclusion up to one month after initial diagnosis or recurrence (local or distant) of breast cancer, PS ≤ 2, Willing and available to invest in the project for the duration of the study, Using a personal smartphone or personal tablet compatible with the "Withings Health Mate" app (iOS 10/android 5.0 and later) and with an internet connection, Affiliated with a social security plan, Having dated and signed an informed consent, Able to read, write and understand French. Exclusion Criteria: Presence of disabling metastases, Moderate to severe cognitive impairment, Persons deprived of liberty or under guardianship, Inability to undergo the medical follow-up of the trial for geographical, social or psychological reasons,
Sites / Locations
- Centre Léon Bérard
- Institut CurieRecruiting
- Institut GODINOTRecruiting
- Institut CurieRecruiting
Arms of the Study
Arm 1
Experimental
Intervention with activity tracker
Women allocated to the intervention arm will used an activity tracker